Todays Updates

Syncom Formulation (58.00) is a Mumbai based small pharmaceutical companies offering more than 250 products in various dosage forms including tablets, capsules, dry syrups, ointments/creams, dry powders, injections and ampoules. Being WHO-GMP certified, company's products are exported to more than 15 countries including China, Vietnam, Latin American Countries Kenya, Uganda, Sudan, Russia, Ukraine, Maldova and Domino Republic. It also offers comprehensive contract manufacturing services including pilot plants, technical services, quality control and regulatory services for both domestic as well as foreign companies. Its prestigious expansion cum modernisation project at Pithampur is near completion. Last fiscal, launched a new division "Cratus Life Care" to expand its operations in domestic market and expects this division to become the driver for growth in the coming years. For FY08 it is expected to clock a turnover of Rs 70 cr and net profit of around Rs 4.50 cr i.e. EPS of Rs 8 on equity of Rs 5.92 cr. Hence, this debt free and constant dividend paying company can be bought at current market cap of Rs 35 cr.

D&H Welding Electrodes (42.00) is one of an established manufacturer of welding consumables inclding submerged arc welding flux and wires, low heat input welding alloys, welding trans and rectifier, manual metal arc electrode etc. Thus it offers a wide range of welding electrodes for diverse applications and has developed various special and ultra-special electrodes to meet the ever increasing and multifarious needs of customers. Last fiscal it successfully commissioned the flux-cored wire project. To maintain its future growth company is planning to expand the existing manufacturing capacity by 2500 MT per annum thru a capex of Rs 3 cr and is putting special thrust on export. Although no extraordinary growth is expected in this company still for FY08 it may do a sale of about Rs 38 cr and net profit of Rs 2.60 cr. This leads to an EPS of Rs 5 on equity of Rs 5.60 cr. Can be bought only at sharp declines.

Led by two technocrats - Jitendra Sura and Tejas Sura, Conart Engineers (45.00) is a small infrastructure company involved in detailed engineering, procurement and construction of industrial, commercial & residential projects. It specializes mainly in civil construction projects for the textile, pharmaceutical, heavy engineering, chemical industries, commercial complexes, effluent treatment systems etc, which involve civil engineering and structural work, sanitation & plumbing, etc. However, company couldn’t capitalize the ongoing boom in infrastructure sector as well as strong industrial growth. For FY07, it reported a flat topline of Rs 19 cr and a decline of 30% in net profit to Rs 0.74 cr. But for H1FY08 things have improved a bit with 30% & 45% growth in topline and bottomline respectively. Still, being a more than three decade old company it has far more potential to perform. Accordingly its is estimated to may end FY08 with revenue of Rs 25 cr and PAT of Rs 1.25 cr i.e. EPS of Rs 4 on small equity of Rs 3 cr. Like Petron Engineering this is also a good takeover candidate and may change hands sooner or later.

Lokesh Machines (142.00) is engaged in the design, development and manufacture of custom built special purpose machines and general purpose CNC (computerized numerical controls) machines along with their components. Presently, it derives 70% revenue from machining division whereas rest 30% comes from auto component division. Company primarily caters to customers in the auto OEM, auto ancillaries and general engineering space with separate dedicated facilities for M&M and Ashok Leyland. Off late, it has also made a foray in the overseas markets and has also got 100 machine order from its technical partner Wenig Wemas-Germany. For the latest Sept qtr, sales grew by 25% to 28 cr and profit increased by 50% to 3.40 cr. To fund its growth plan company came out with an IPO at Rs.140 per share in April 2006 and raised Rs.42 cr. On listing day it hit a high of 300 Rs, whereas currently it’s available at 50% discount to that. For FY08 it is expected to clock a turnover of 110 cr and PAT of 14.50 cr which leads to an EPS of Rs 12 on equity of Rs 11.80 cr. Scrip has the potential to touch Rs 200 in few months.

~ all the above from saarthi.blogspot.com

********************************

BUY GTC INDS. @674
BUY CURRENT MONTH CALL/PUT
This is an option call and the sl in f/o is to be considered only at closing,an intraday sl should not be considered


Buy C1 of INFOSYS of sp 1710 @ 68.10 with a target of 90 and sl of 1630 in f/o
XTL BREAKOUT
This parameter has a confirmation of closing for the first time above the 12 day weekly moving average.


Buy RCOM @ 790 & Buy BRITANIA @ 1538
SAR
This parameter gives you upper target and reverse target after stoploss

~All these from mystockcopy

******************************